views

Proteome Sciences – emphasises “strong development” including increased “cash reserves”. Er, what about those borrowings?!

Describing itself as “a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification”, Proteome Sciences (PRM) has issued a trading update commencing that it “is pleased to report that it has continued to show strong growth” and concluding that the “business is strongly positioned for 2023”. So what of a current more than 22% higher share price response to 4.6p?

NEWSFLOW

Proteome (#PRM) bullish trading statement but warns of H2 weighting, says Brexit neutral

NEWSFLOW

Proteome (#PRM) upbeat FY trading statement

views

Zak Mir's Great Request Show: Immupharma, Oxford Biomedica, Proteome Sciences

I may be fired by midnight. My fate is in your hands. Vote now in the reader poll HERE. If I avoid a P45  andyou want me to analyse a stock for you just drop me a line at sqmir@hotmail.com - Today I look at shares in Immupharma, Oxford Biomedica and Proteome Sciences setting share price targets for all three stocks.

views

Zak Mir's Bull Call Of The Day: Proteome Sciences: 32p Price Channel Target

Although we may have had the feeling since the beginning of the year that shares of Proteome Sciences were ready to start bottoming out, so far it has been an extended process, which has probably taken most traders by surprise. 

views

Zak Mir's Bull Call Of The Day: Proteome Sciences: Broadening Triangle Rebound Points To 32p

In the case of Proteome Sciences (PRM) we have an overall broadening triangle formation on the daily chart, one that can be drawn from as long ago as November. 

NEWSFLOW

Poteome Sciences (#PRM) - £2.5million placing at 18p

views

Zak Mir's Bull Call Of The Day: Proteome Sciences Return To 30p Price Channel Top

What is evident on the daily chart of Proteome Sciences in recent months is the way that 50 day moving average at 21p has been a key player in the technicals for this stock

NEWSFLOW

Proteome (#PRM) - positive update on Sysquant ( when's the placing?)

views

Proteome Sciences: Extended Base Under 30p Implies 40p Plus Target

There will be few who would disagree that the post June period for Proteome Sciences (PRM) is probably best forgotten. This is because, following the early summer bull trap reversal through 70p, we were treated to a punishing two stage decline.